Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial (vol 382, e070464, 2023)

被引：0
|
作者：
不详
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2023年 / 382卷
关键词：
D O I：
10.1136/bmj.p2193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial
    Mohraz, Minoo
    Vahdat, Katayoun
    Ghamari, Seyyed-Hadi
    Abbasi-Kangevari, Mohsen
    Ghasemi, Erfan
    Ghabdian, Yasaman
    Rezaei, Negar
    Pouya, Maryam Amini
    Abdoli, Asghar
    Malekpour, Mohammad-Reza
    Koohgir, Keyvan
    Moghaddam, Sahar Saeedi
    Tabarsi, Payam
    Moghadami, Mohsen
    Khorvash, Farzin
    Khodashahi, Rozita
    Salehi, Mohammadreza
    Hosseini, Hamed
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 382
  • [2] Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial
    Mohraz, Minoo
    Vahdat, Katayoun
    Ghamari, Seyyed-Hadi
    Abbasi-Kangevari, Mohsen
    Ghasemi, Erfan
    Ghabdian, Yasaman
    Rezaei, Negar
    Pouya, Maryam Amini
    Abdoli, Asghar
    Malekpour, Mohammad-Reza
    Koohgir, Keyvan
    Moghaddam, Sahar Saeedi
    Tabarsi, Payam
    Moghadami, Mohsen
    Khorvash, Farzin
    Khodashahi, Rozita
    Salehi, Mohammadrez
    Hosseini, Hamed
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 382
  • [3] Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults
    Mohraz, Minoo
    Salehi, Mohammadreza
    Tabarsi, Payam
    Abbasi-Kangevari, Mohsen
    Ghamari, Seyyed-Hadi
    Ghasemi, Erfan
    Pouya, Maryam Amini
    Rezaei, Negar
    Ahmadi, Naser
    Heidari, Kazem
    Malekpour, Mohammad-Reza
    Nasiri, Mojtaba
    Amirzargar, Ali Akbar
    Moghaddam, Sahar Saeedi
    Larijani, Bagher
    Hosseini, Hamed
    BMJ OPEN, 2022, 12 (04):
  • [4] Correction: Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults (vol 12 artn e056872, 10.1136/bmjopen-2021-056872 )
    Mohraz, M.
    Salehi, M.
    Tabarsi, P.
    BMJ OPEN, 2022, 12 (11):
  • [5] Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    Zhu, Fengcai
    Huang, Shoujie
    Liu, Xiaohui
    Chen, Qi
    Zhuang, Chunlan
    Zhao, Hui
    Han, Jinle
    Jaen, Anjuli May
    Do, Thai Hung
    Peter, Jonathan Grant
    Dorado, Alexander Gonzalez
    Tirador, Louie S.
    Zabat, Gelza Mae A.
    Villalobos, Ralph Elvi M.
    Gueco, Gemalyn Pineda
    Botha, Lauren Livia Greta
    Pertuz, Shirley Patricia Iglesias
    Tan, Jiaxiang
    Zhu, Kongxin
    Quan, Jiali
    Lin, Hongyan
    Huang, Yue
    Jia, Jizong
    Chu, Xiafei
    Chen, Junyu
    Chen, Yixin
    Zhang, Tianying
    Su, Yingying
    Li, Changgui
    Ye, Xiangzhong
    Wu, Ting
    Zhang, Jun
    Xia, Ningshao
    LANCET RESPIRATORY MEDICINE, 2023, 11 (12): : 1075 - 1088
  • [6] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
    Xia, Shengli
    Zhang, Yuntao
    Wang, Yanxia
    Wang, Hui
    Yang, Yunkai
    Gao, George Fu
    Tan, Wenjie
    Wu, Guizhen
    Xu, Miao
    Lou, Zhiyong
    Huang, Weijin
    Xu, Wenbo
    Huang, Baoying
    Wang, Huijuan
    Wang, Wei
    Zhang, Wei
    Li, Na
    Xie, Zhiqiang
    Ding, Ling
    You, Wangyang
    Zhao, Yuxiu
    Yang, Xuqin
    Liu, Yang
    Wang, Qian
    Huang, Lili
    Yang, Yongli
    Xu, Guangxue
    Luo, Bojian
    Wang, Wenling
    Liu, Peipei
    Guo, Wanshen
    Yang, Xiaoming
    LANCET INFECTIOUS DISEASES, 2021, 21 (01): : 39 - 51
  • [7] Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
    Tanriover, Mine Durusu
    Doganay, Hamdi Levent
    Akova, Murat
    Guner, Hatice Rahmet
    Azap, Alpay
    Akhan, Sila
    Kose, Sukran
    Erdinc, Fatma Sebnem
    Akalin, Emin Halis
    Tabak, Omer Fehmi
    Pullukcu, Husnu
    Batum, Ozgur
    Yavuz, Serap Simsek
    Turhan, Ozge
    Yildirmak, Mustafa Taner
    Koksal, Iftihar
    Tasova, Yesim
    Korten, Volkan
    Yilmaz, Gurdal
    Celen, Mustafa Kemal
    Altin, Sedat
    Celik, Ilhami
    Bayindir, Yasar
    Karaoglan, Ilkay
    Yilmaz, Aydin
    Ozkul, Aykut
    Gur, Hazal
    Unal, Serhat
    LANCET, 2021, 398 (10296): : 213 - 222
  • [8] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
    Han, Bihua
    Song, Yufei
    Li, Changgui
    Yang, Wanqi
    Ma, Qingxia
    Jiang, Zhiwei
    Li, Minjie
    Lian, Xiaojuan
    Jiao, Wenbin
    Wang, Lei
    Shu, Qun
    Wu, Zhiwei
    Zhao, Yuliang
    Li, Qi
    Gao, Qiang
    LANCET INFECTIOUS DISEASES, 2021, 21 (12): : 1645 - 1653
  • [9] A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
    Akova, Murat
    Unal, Serhat
    TRIALS, 2021, 22 (01)
  • [10] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
    Ella, Raches
    Vadrevu, Krishna Mohan
    Jogdand, Harsh
    Prasad, Sai
    Reddy, Siddharth
    Sarangi, Vamshi
    Ganneru, Brunda
    Sapkal, Gajanan
    Yadav, Pragya
    Abraham, Priya
    Panda, Samiran
    Gupta, Nivedita
    Reddy, Prabhakar
    Verma, Savita
    Rai, Sanjay Kumar
    Singh, Chandramani
    Redkar, Sagar Vivek
    Gillurkar, Chandra Sekhar
    Kushwaha, Jitendra Singh
    Mohapatra, Satyajit
    Rao, Venkat
    Guleria, Randeep
    Ella, Krishna
    Bhargava, Balram
    LANCET INFECTIOUS DISEASES, 2021, 21 (05): : 637 - 646
12345